Drugmakers Merck and Novartis recently updated their 340B contract pharmacy restrictions, modifying what states are exempt from such policies following [...] Read More »
Category: Contract Pharmacy Protection Bills
A 340B program advocate this week condemned a new GOP U.S. House bill that would prohibit covered entities from using [...] Read More »
Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...] Read More »
As state legislatures ramp up efforts to protect contract pharmacy access, drug industry lawsuits against existing state laws continue to [...] Read More »
A Washington D.C. dark money group with White House ties recently upped its attacks on 340B contract pharmacy access bills [...] Read More »
News Alert
Dark-Money 340B Attacks, Rebate Model Among Key Concerns at 340B Coalition Winter Conference
Concerns over a highly charged and misleading dark-money campaign targeting state contract pharmacy access bills and the legal fight surrounding [...] Read More »
340B contract pharmacy access bills could cost states millions and employer health plans more, according to a new study funded [...] Read More »
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] Read More »
Conservative groups and advocates have recently ramped up efforts to combat the growing number of state 340B contract pharmacy access [...] Read More »
Ireland-based Alkermes announced this week that it will become the third drugmaker to reinstate contract pharmacy restrictions in Kansas and [...] Read More »